Literature DB >> 7821756

Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation.

A C Young1, S G Nathenson, J C Sacchettini.   

Abstract

The three-dimensional structures of three human and two murine class I molecules, in complex with single peptides and with mixtures of endogenous peptides, have now been determined to high resolution. These structures have afforded important insights into the way in which antigenic peptides are bound by an MHC class I molecule, and how a given MHC molecule can bind a large number and variety of peptides, for presentation to a T cell receptor. Peptides are bound in a cleft located in the alpha 1/alpha 2 domain of a class I molecule. They are tethered by an array of hydrogen bonding interactions many of which are conserved among the different structures. Binding is also accomplished through van der Waals interactions between two or three peptide residues and complementary pockets in the cleft. The location and the characteristics of its pockets are unique to a given MHC class I molecule, and so determine the identity of the anchor residues of the set of peptides that bind. The antigenic epitope recognized by the TCR consists of residues on the MHC as well as the side chains of those peptide residues that point out from the cleft. The various strategies used to expand the repertoire of peptides bound and presented are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7821756     DOI: 10.1096/fasebj.9.1.7821756

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  MHC-I prediction using a combination of T cell epitopes and MHC-I binding peptides.

Authors:  Tal Vider-Shalit; Yoram Louzoun
Journal:  J Immunol Methods       Date:  2010-10-12       Impact factor: 2.303

2.  Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes.

Authors:  Miranda Z Smith; C Jane Dale; Robert De Rose; Ivan Stratov; Caroline S Fernandez; Andrew G Brooks; Jason Weinfurter; Kendall Krebs; Cara Riek; David I Watkins; David H O'connor; Stephen J Kent
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Structural engineering of pMHC reagents for T cell vaccines and diagnostics.

Authors:  Vesselin Mitaksov; Steven M Truscott; Lonnie Lybarger; Janet M Connolly; Ted H Hansen; Daved H Fremont
Journal:  Chem Biol       Date:  2007-08

4.  The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide.

Authors:  G K Balendiran; J C Solheim; A C Young; T H Hansen; S G Nathenson; J C Sacchettini
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

5.  Antigenic properties and processing requirements of 65-kilodalton mannoprotein, a major antigen target of anti-Candida human T-cell response, as disclosed by specific human T-cell clones.

Authors:  R Nisini; G Romagnoli; M J Gomez; R La Valle; A Torosantucci; S Mariotti; R Teloni; A Cassone
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

6.  Detecting site-specific physicochemical selective pressures: applications to the Class I HLA of the human major histocompatibility complex and the SRK of the plant sporophytic self-incompatibility system.

Authors:  Raazesh Sainudiin; Wendy Shuk Wan Wong; Krithika Yogeeswaran; June B Nasrallah; Ziheng Yang; Rasmus Nielsen
Journal:  J Mol Evol       Date:  2005-03       Impact factor: 2.395

Review 7.  [Malaria--biological aspects of an infectious disease of importance to humans].

Authors:  J P Hildebrandt
Journal:  Naturwissenschaften       Date:  1996-08

8.  The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2Kb: A Combined Molecular Dynamics and Experimental Study.

Authors:  Esam Tolba Abualrous; Sunil Kumar Saini; Venkat Raman Ramnarayan; Florin Tudor Ilca; Martin Zacharias; Sebastian Springer
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

Review 9.  Introduction: MHC/KIR and governance of specificity.

Authors:  Adrian Kelly; John Trowsdale
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.